Global iodine production is heavily concentrated in Chile and Japan, which together supply the vast majority of world output. This geographic concentration means that disruptions — such as Chilean mining-sector labor actions or Japanese energy-cost spikes — can rapidly tighten global availability and push up prices, leaving US buyers with limited alternative sources in the short term.

Iodine used in pharmaceutical or food-contact applications may be subject to FDA oversight depending on its intended use and formulation. Importers should ensure that purity specifications and labeling align with the intended downstream application, and consult a licensed customs broker or regulatory counsel to confirm whether FDA prior notice or other admissibility requirements apply to their specific shipment.